Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
Richard A. Koup, Mario Roederer, Laurie Lamoreaux et al. · 2010
Read Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses by Richard A. Koup, Mario Roederer, Laurie Lamoreaux et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009015.txt.
Description
Richard Koup and co-authors tested a two-step vaccine plan against HIV, in PLOS ONE in 2010. A vaccine must raise both antibodies and T cells tuned to HIV-1. Prime-boost plans use two different vaccine types in sequence. Earlier animal work showed such mixes can raise strong, broad T-cell responses.
The team primed with a DNA vaccine, then boosted with an adenoviral vector vaccine. The DNA first step made the boost work harder. Both antibody levels and T-cell responses against HIV-1 grew stronger. Better priming could stretch the power of vaccines that are weak alone.
Catalog record
| CREATOR | Richard A. Koup, Mario Roederer, Laurie Lamoreaux et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009015